40
Participants
Start Date
December 5, 2018
Primary Completion Date
August 2, 2021
Study Completion Date
October 4, 2021
Lactobacillus salivarius V4II-90
7 months intervention study: with a screening period of 12 weeks after which participants GBS+ women will be randomized and start the orally intake of 1 capsule per day of the Lactobacillus salivarius V4II-90 (1\*10E9 CFU) probiotic supplement over a 12 weeks period. A visit will then be completed one month after delivery.
Placebo
7 months intervention study: with a screening period of 12 weeks after which participants GBS+ women will be randomized and start the orally intake of 1 capsule per day of the placebo supplement over a 12 weeks period. A visit will then be completed one month after delivery.
Hospital Universitario La Paz, Madrid
Casen Recordati S.L.
INDUSTRY
ProbiSearch SL
INDUSTRY